Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Influenza Vaccines
Research on influenza vaccines discussed by S. Chun and co-researchers
December 31st, 2008
New investigation results, 'Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins,' are detailed in a study published in Vaccine. According to a study from Ottawa, Canada, "The fusion peptide is the only universally conserved sequence in the hemagglutinins of all 16 subtypes of influenza A and two genetic lineages of influenza B viruses. Here, peptides selected by bioinformatics approach were modified and conjugated to overcome serious technical hurdles such as the high hydrophobicity and weak immunogenicity of the viral fusion peptides." "Antibodies generated against fusion...
Source: Vaccine Weekly (2008-12-31)
|
